Private Equity
Pittsburgh, Pennsylvania-based CivicScience, a polling and data mining company, is adding investor and Dallas Mavericks owner Mark Cuban to its board, the company announced. He will serve a four-year term beginning January 2013.
2 min read · 11 January 2013
Flexstar Technology, the California-based data storage industry technology company, appointed Stephen Memmen as president and CEO, the company announced. Audax Group and Rigel Associates are investors in the company.
2 min read · 11 January 2013
We've got Jack Lew, Lindsay Lohan and the Traveling Wilburys in peHUB's Friday First Read. Top that.
1 min read · 11 January 2013
FireEye, the California-based security firm, announced a new $50 million round and a slew of new executive appointments. Investors including Silicon Valley Bank, Juniper Networks, Goldman Sachs, Norwest Venture Partners and Sequoia Capital are reported to have participated in the round.
3 min read · 10 January 2013
True Ventures led a $25 million Series C financing for Streetline Inc., the California-based company that aims to optimize parking. Sutter Hill Ventures, RockPort Capital Partners, and Fontinalis Partners were joined by Citi and Qualcomm Ventures also participated in the round.
4 min read · 10 January 2013
ScaleArc, the database infrastructure software firm based in California, completed a $12.3 million round, the company announced. Accel Ventures led the round and Trinity Ventures and Nexus Ventures also participated in the round.
3 min read · 10 January 2013
The big news last week came in the wake of a SEC inquiry that concluded former Warren Buffett lieutenant David Sokol wasn’t guilty of any insider trading. But, to the PE world, the biggest news was...
2 min read · 07 January 2013
The 'away' team takes it on this NFL playoff weekend! Check out peHUB's top 10 stories, including guest posts from Menlo Ventures' Mark Siegel, author Mahendra Ramsinghani, LDJ Capital's David Drake, and AARM Corp. CEO Gitanjali M. Swamy.
1 min read · 07 January 2013
The fiscal cliff came and went, and now, going into 2013 it seems private equity firms across the country have two things to thank Washington for—or at least that’s one conclusion we can draw from Deloitte’s PE preview report.
2 min read · 04 January 2013
Heart Metabolics Limited, the UK-based developer of a drug to treat heart failure for hypertrophic cardiomyopathy patients, closed a $4 million Series A round from investors including the Trans Tasman Commercialisation Fund in Melbourne, Australia and AshHill Investments, based in the U.S. Heart Metabolics also announced changes to its board as part of the financing.
3 min read · 04 January 2013
